Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of J147 in Healthy Volunteers
NCT03838185Phase 1Completed
- Start
- Jan 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) comparing J147 with Placebo (2 arms). Primary endpoints: Incidence of treatment-emergent adverse events, Number of subjects with abnormal electrocardiogram and 5 more. Started Jan 2019; status: completed.
02
Drugs
j147
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03838185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03838185.